The Second International In-Vivo Monitoring
Intercomparison Program for Whole Body Counting Facilities by Canadian and
United States Agencies.
Gary H. Kramer*, Robert
M. Loesch§ and Peter C. Olsen¶.
* Human Monitoring Laboratory, Radiation
Protection Bureau, 775 Brookfield Road, Ottawa, Ontario, K1A 1C1
(Gary_H_Kramer@hc-sc.gc.ca, www.hc-sc.gc.ca/ncrc/)
§ DOELAP Program Manager, USDOE, Office of
Health, Washington, DC 20585.
¶ Battelle Pacific Northwest National Laboratory,
PO Box 999, Richland, WA 99352 (Operated for the U.S. Department of Energy under
contract #DE-AC06-76RLO-1830.
INTRODUCTION
The Canadian National
Calibration Reference Centre for In-Vivo
Monitoring*
(Kramer and Limson-Zamora 1994) and the United States Department of Energy
(DOE) collaborated to offer a second international in vivo intercomparison program to whole body counting facilities
in 1996 following the success of the first International Intercomparison
(Kramer et al. 1999). The HML
fabricated a Reference Female phantom shell (Kramer et al. 1991) and Battelle
Pacific Northwest National Laboratory (PNNL) filled the shell with radioactive
tissue-substitute polyurethane to simulate a uniform fission-product
distribution in soft tissues.
The intercomparison program consisted of 45 facilities in
23 countries. Each counting system was given a two-letter identification code
(ID) so some facilities had multiple codes.
The total number of counting systems in this program was 63. For example, two facilities have had four
codes assigned to them.
Time estimates for the length of the program were based
on the previous intercomparison program (Kramer et al. 1999). It was found that the average shipping time
was 6.3 days and the average time at a facility was 11.3 days. Total shipping plus facility time was 17.6
days which is less than the assumed three weeks used for planning
purposes. Therefore the 21-day
time-frame was chosen for this intercomparison program and were expected to
take one week to perform measurements and two weeks were allowed for
shipping/handling the phantom to the next facility. Based on these estimates, the length of the intercomparison was
estimated as 138 weeks. The program
began in June 1996 and should have ended in February 1999; however, such
factors as shipping delays, equipment breakdown, and custom’s clearance
contributed to a slight lengthening of the program. The program officially ended on 24-March-1999, when the phantom
arrived back at the HML from the last participant’s laboratory. The average shipping time for this
intercomparison was 7.2 days (median value 5 days) and the average time at a
facility was 15.6 days (median value 11 days).
Total shipping plus facility time was 22.8 days per facility (16 days
per facility using median values) which was slightly more than 21 day
time-frame.
METHODS AND MATERIALS
The phantom was filled with soft-tissue substitute material and an undisclosed
quantity of
two fission product
radionuclides (137Cs and 60Co ). The activity in the
phantom was homogeneously distributed throughout all sections and was proportional to the volume of that
section. The phantom also contained 40K
homogeneously distributed in an amount similar to a Reference Female, to
produce a representative Compton background in the resulting spectra.
The amounts of the radionuclides on 08-May-96, 20:00 GMT
(Greenwich Mean Time) were: 40K:
2.99 " 0.15 kBq
, 60Co: 19.89 " 0.19 kBq , 137Cs: 20.05 " 0.17 kBq. The participants were unaware of which nuclides were in the
phantom. Each facility was asked to
determine the number, identity and amount of the radionuclides in the
phantom. Participants were advised to
examine the energy range of 200 - 2000 keV.
Each facility was asked to make an estimate of the precision (P) and estimate their Minimum Detectable
Activity (MDA).
Determination of
activity: Participants were requested to determine the
activity of the identified nuclides in the phantom by two methods. The first method was to use their normal
"man-sized" calibration factor (method-1). The comparison of activity estimated in this manner to the actual
activity in the phantom gives the phantom-size dependency for the facility’s
whole body counter. The second method
was to use an efficiency corrected for the size of the female phantom
(method-2); if the facility did not have any correction factors, then no
results were reported. How this
size-corrected factor was developed was not known to the organisers of the
intercomparison and was left to the participants’ best judgement.
The accuracy of counting was obtained by evaluating the
bias. The bias, B, is given by the
following expression (HPS 1996, AECB 1997):
B ~ = ~ 100 ~ * ~ {(A sub i - A)} over A~~~~~(%) |
1 |
Where Ai is the
observed value obtained by either method-1 or method-2 and A is the true value.
Estimation of counting
precision: Participants were requested to count the
phantom repeatedly; without moving it. Participants were asked to supply gross
counts, net counts and the counting time for each of the replicate
measurements. This test was to estimate stability of the counting system (gross
counts) and the effect of analysis on precision (net counts). Observed
precision, OP, was then estimated by the following expression:
|
2 |
Where OP is the observed
precision, Ai is the observed value (from gross counts or net
counts), M is the mean of that data set, and N is the number of measurements
(usually 5).
Radioactive decay is governed by Poisson statistics and
the ideal whole body counter should have a precision close to the Poisson
statistic. Poisson precision, PP, was
estimated from the following expression:
|
3 |
Where PP is the Poisson
precision, and M is the mean of the data set (gross count or net count). It follows that the ideal whole body counter
should have a ratio of OP:PP of unity.
Determination of the
Minimum Detectable Activity (MDA): Each facility was asked to calculate
an MDA for all the radionuclides, except 40K, detected in the
phantom by measuring either an uncontaminated person or use a phantom
containing an amount of 40K expected to be found in Reference
Female. The following expression was
used to calculate MDA values:
MDA ~ = ~ 4.65 ~ * ~ SQRT {N} over {E ~ * ~ T} ~ + ~ 3 over {E ~ * ~ T} |
4 |
Where MDA is the minimum
detectable activity (Bq), N is the counts in the background region under investigation,
E is the counting efficiency (cps/Bq), and T is the counting time (sec).
The MDA of a counting system is a function of the ambient
background, the amount that background has been reduced by the shielding, the
detector type, and the detector size.
Although background count rate data was not supplied by the participants
it was possible to extract it from the information supplied. The background counts were obtained from the
facility’s MDA value for 137Cs.
The MDA was divided by the counting efficiency, E (calculated from the
net counts and the facilities estimated activity), and the counting time,
T, as shown below.
|
5 |
The background count
rate is then obtained by dividing the background counts, N, by the counting
time. For example, the background
counts in the 137Cs photopeak region varies from 0.002 counts per
second (scanning bed with two low efficiency Ge detectors in a steel room) to
73 counts per second (Large NaI detector in a steel room). One facility had a
very high background count rate of 2350 counts per second (large unshielded
plastic phosphor scintillation detector).
MDA’s were
time-normalised to 3000 sec by applying a correction defined by:
|
6 |
Where MDAnorm
is the time-normalised value, MDA is the reported value, T1 was the
counting time used to determine MDA, and T2 is the normalisation
time (3000 sec).
RESULTS AND DISCUSSION
Identification of
unknowns: All facilities correctly
identified the unknown radionuclides as 60Co and 137Cs. All counting systems were able to identify
the unknown radionuclides except AV, presumably due to the poor resolution of
the detector system.
Determination of
activity: Results for the facilities are shown in Table 1. Fewer facilities supplied activities using
method-2. A normal probability plot for
137Cs and 60Co(method-1) bias data after the outliers
have been removed and show that the data are now normally distributed and each
can be assumed to belong to a single set.
All things being equal, one would expect a distribution
of results about a mean of zero bias for 137Cs and 60Co bias (method-1); however, this will depend
on the calibration protocol of each participating facility. For example, a systematic bias would be
introduced by a facility that calibrated its counting system with a phantom of
different size or geometry to the one being measured.
The data show that most facilities have little difficulty
in meeting the US and Canadian performance targets for bias (HPS 1996, AECB
1997). Data (method 1) are
significantly different from zero bias (t-test, "=0.05) and have means of 6.7 " 10.1 (1.3 Fmean) and 5.6 " 7.2 (1.1 Fmean), respectively. Data (method 2) are not significantly different from zero bias
(t-test, "=0.05) and have a mean of 3.5 " 8.4 (1.8 Fmean) showing that size correction factors have
improved the results; however, the 60Co data (method 2) in Fig. 4
are significantly different from zero bias (t-test, "=0.05) and have a mean of 6.9 " 9.4 (2.1 Fmean) showing that size correction factors have not
improved these results.
Outliers excepted, a first inspection shows little
difference between method-1 and method-2 for either radionuclide. This is proved by t-testing the 137Cs
method-1 and method-2 data, and the 60Co method-1 and method-2
data. In both cases the null hypothesis
is accepted, i.e., there is no difference between the method-1 and method-2 for
either radionuclide. In other words,
size dependency is not an issue for the Reference Female BOMAB phantom.
Analysing the bias data as a function of counting
geometry, outliers excepted, there seems to be little difference between the
different counting geometries. Performing
Analysis of Variance on the data (less the Arc geometry and the Scanning
Detectors where there are too few values) one finds that the null hypothesis,
that all counting systems give the same bias values, is accepted for all cases. 137Cs (method-1), (F = 2.00, p =
0.124); 60Co (method-1), (F
= 1.11, p = 0.352); 137Cs (method-2), (F = 1.64, p = 0.225); 60Co
(method-2),(F = 0.25, p = 0.782).
Precision of
counting: Results for the
facilities are shown in Table 1. Testing the gross count data one finds that
the null hypothesis, that the mean is no different from unity, is accepted for
the Ge detector based systems (t-test, "=0.05, P=0.17), i.e., the variation
is due to Poisson statistics. However,
the null hypothesis is rejected for the NaI detector based systems (t-test, "=0.05, P=0.01) and the mean is
different from unity, i.e., the variation is not due to Poisson
statistics.. Other factors must have
influenced the values of the data identified as outliers. The cause is not known.
Testing the net count data one finds that the null
hypothesis, that the mean is no different from unity, is accepted for the Ge
detector based systems (t-test, "=0.05, P=0.67). Similarly, the null hypothesis is rejected for the NaI detector
based systems (t-test, "=0.05, P=0.00) and the mean is different from unity. It must be concluded that the use of NaI
detectors is introducing a systematic uncertainty compared with Ge detector
based systems.
Determination of
the MDA: Analysis of 137Cs MDA values versus counting time only
suggests that lengthening the counting time improves MDA. Similarly, the analysis of time-normalised 137Cs
MDA values versus total shield thickness, only suggests that increasing shield
thickness decreases MDA.
The time-normalised 137Cs MDA data analysed as
a function of total detector volume for NaI detector counting systems is also
scattered and although no statistical testing has been performed the trend
seems clearer. Larger detection systems
tend to have lower MDA’s. Similarly, the analysis of time-normalised 137Cs
MDA values versus total relative
efficiency for Ge counting systems shows that larger efficiency systems have
lower MDA values.
CONCLUSIONS
The intercomparison has
shown that the whole body counters that participated in this intercomparisons
are not phantom-size dependent when
measuring a Reference Female phantom.
Photon energy, at least within the ranges tested, does not affect this
dependency. The use of phantom-size
correction factors improved facilities’ performance for 137Cs, but
not 60Co. The whole body
counting configurations statistically tested were shown to perform equally
well. Comparison of measured counting precision with predicted Poisson counting
statistics showed that the NaI detector based systems seemed to have a
systematic uncertainty in addition to Poisson variability. Contrarily, this was not found for Ge
detector based systems. MDA data
supplied by the participants was scattered (14 - 3500 Bq for 137Cs
and 9 - 460Bq for 60Co). No
relationship was found between the facilities’s MDA values and shielding
thickness or counting time. It was
clear that counting systems with more detector volume (or higher relative
efficiency) had lower MDA values than systems with smaller detector volume (or
lower relative efficiency).
REFERENCES
American National
Standards Institute. Performance
Criteria for Radiobioassy. McLean:
Health Physics Society; HPS N13.30-1996; 1996.
Atomic Energy Control
Board. Technical and Quality Assurance
Standards for Dosimetry Services in Canada.
Ottawa: Atomic Energy Control
Board; Atomic Energy Control Board Standard, S-106, 1997.
Kramer G. H.; Noel L.;
Burns L. The BRMD BOMAB Phantom
Family. Health Phys. 61(6): 895-902;
1991
Kramer G. H.; Limson
Zamora M. The Canadian National
Calibration Reference Centre for Bioassay and In-Vivo Monitoring: A programme summary. Health Phys. 67(2): 192-196; 1994.
Kramer G.H.; Loesch
R.M.; Olsen P.C. The 1993
Intercomparison of the measurement of in
vivo radioactivity. Rad Prot.
Dosim. 86(3): 197-206; 1999.
Table 1: Identification, bias and precision, and MDA results. Blank space indicates no results received.
|
137Cs Bias (%) |
60Co Bias (%) |
Ratio OP/PP |
|
|
|||
ID Code |
Method-1 |
Method-2 |
Method-1 |
Method-2 |
Gross counts |
Net Counts |
MDACs (Bq) |
MDACo (Bq) |
AA |
14.9 |
0.5 |
10.5 |
-3.5 |
1.8 |
2.2 |
35 |
41 |
AB |
21.4 |
|
25.6 |
|
0.9 |
1.2 |
343 |
90 |
AC |
1.7 |
|
0.1 |
|
|
|
41 |
28 |
AD |
6.6 |
|
-1.7 |
|
1.4 |
1.5 |
104 |
70 |
AE |
-30.4 |
|
-35.4 |
|
0.7 |
1.0 |
148 |
96 |
AF |
-27.9 |
|
-37.4 |
|
1.5 |
1.5 |
167 |
114 |
AG |
-26.9 |
|
-33.8 |
|
1.6 |
1.9 |
155 |
108 |
AH |
11.2 |
|
11.9 |
|
3.1 |
3.0 |
27 |
44 |
AJ |
4.0 |
|
1.6 |
|
0.6 |
1.4 |
76 |
166 |
AK |
19.6 |
|
18.1 |
|
1.2 |
1.1 |
152 |
218 |
AL |
-6.8 |
|
8.5 |
|
0.4 |
6.7 |
56 |
54 |
AM |
-9.1 |
|
-5.3 |
|
1.3 |
0.9 |
57 |
15 |
AN |
0.1 |
|
-2.9 |
|
1.0 |
1.0 |
14 |
9 |
AP |
8.4 |
7.1 |
12.6 |
11.2 |
|
1.3 |
67 |
67 |
AR |
16.5 |
|
0.5 |
|
1.5 |
0.9 |
28 |
16 |
AS |
9.6 |
|
8.5 |
|
1.0 |
|
185 |
185 |
AT |
8.5 |
|
7.6 |
|
|
2.1 |
94 |
78 |
AV |
-19.1 |
|
|
|
1.6 |
2.3 |
80 |
0 |
AW |
11.3 |
|
11.6 |
|
|
1.2 |
3500 |
0 |
AX |
|
-8.5 |
|
|
1.3 |
1.4 |
300 |
|
AY |
-2.3 |
|
-2.8 |
|
1.4 |
1.5 |
223 |
113 |
AZ |
-1.7 |
|
1.9 |
|
1.2 |
1.4 |
104 |
54 |
BA |
22.6 |
29.6 |
-7.3 |
-2.0 |
1.3 |
4.4 |
306 |
273 |
BB |
2.7 |
|
7.7 |
|
|
1.6 |
70 |
50 |
BC |
-3.7 |
|
-37.5 |
|
5.9 |
1.4 |
374 |
348 |
BD |
-3.8 |
|
-32.8 |
|
3.7 |
1.6 |
409 |
351 |
BE |
-6.3 |
|
-26.7 |
|
2.6 |
3.9 |
24 |
28 |
BF |
4.3 |
-7.5 |
26.9 |
18.8 |
0.7 |
0.7 |
105 |
69 |
BG |
23.2 |
|
28.1 |
|
1.6 |
1.9 |
70 |
80 |
BH |
-0.8 |
-5.4 |
6.5 |
|
0.8 |
1.2 |
59 |
53 |
BJ |
7.6 |
2.5 |
1.1 |
-4.8 |
1.0 |
1.8 |
70 |
50 |
BK |
20.0 |
7.7 |
16.8 |
15.9 |
0.2 |
1.1 |
85 |
67 |
BL |
-4.7 |
-0.6 |
-3.1 |
-0.7 |
1.3 |
1.1 |
50 |
55 |
BM |
8.9 |
|
3.0 |
|
1.3 |
1.2 |
360 |
460 |
BN |
19.8 |
|
6.8 |
|
5.1 |
5.1 |
145 |
142 |
BP |
-5.9 |
|
14.0 |
|
1.1 |
1.6 |
95 |
80 |
BR |
12.1 |
4.3 |
9.7 |
6.7 |
1.7 |
1.0 |
130 |
115 |
BS |
28.0 |
18.5 |
28.1 |
22.0 |
0.5 |
0.7 |
20 |
15 |
BT |
8.8 |
3.1 |
-2.2 |
-4.1 |
0.6 |
0.4 |
300 |
230 |
Table 1 (cont): Identification, bias and precision, and MDA results. Blank space indicates no results received.
|
137Cs Bias (%) |
60Co Bias (%) |
Ratio OP/PP |
|
|
|||
ID Code |
Method-1 |
Method-2 |
Method-1 |
Method-2 |
Gross counts |
Net Counts |
MDACs (Bq) |
MDACo (Bq) |
BV |
1.0 |
-4.1 |
1.4 |
1.4 |
1.2 |
3.6 |
100 |
80 |
BW |
-1.2 |
|
5.4 |
|
5.7 |
5.8 |
30 |
18 |
BX |
-0.6 |
-5.7 |
-17.0 |
-20.1 |
5.7 |
3.4 |
61 |
43 |
BY |
10.8 |
|
9.3 |
|
0.9 |
0.7 |
72 |
49 |
BZ |
14.2 |
|
10.1 |
|
0.7 |
1.2 |
48 |
21 |
CA |
-13.1 |
|
-10.1 |
|
0.9 |
0.9 |
49 |
34 |
CB |
0.6 |
|
2.4 |
|
2.7 |
1.2 |
126 |
95 |
CC |
8.3 |
-1.4 |
7.6 |
0.1 |
2.1 |
2.6 |
40 |
40 |
CD |
9.2 |
0.4 |
14.9 |
5.3 |
11.7 |
2.1 |
125 |
125 |
CE |
-8.0 |
|
-16.2 |
|
1.4 |
0.6 |
77 |
62 |
CF |
18.8 |
22.0 |
8.5 |
11.0 |
1.6 |
3.3 |
158 |
178 |
CG |
27.0 |
|
22.2 |
|
1.3 |
1.3 |
50 |
53 |
CH |
7.2 |
16.0 |
10.8 |
24.9 |
|
2.3 |
60 |
60 |
CJ |
13.9 |
9.9 |
12.6 |
6.2 |
1.0 |
0.4 |
150 |
150 |
CK |
8.8 |
5.7 |
9.0 |
6.7 |
0.8 |
5.1 |
43 |
32 |
CL |
3.1 |
-2.6 |
2.9 |
-1.3 |
11.3 |
9.4 |
44 |
28 |
CM |
13.2 |
|
13.9 |
|
0.8 |
0.8 |
70 |
72 |
CN |
80.1 |
78.6 |
|
|
1.9 |
4.2 |
35 |
|
CP |
14.5 |
|
-17.1 |
|
0.9 |
2.1 |
78 |
94 |
CR |
6.1 |
|
1.9 |
|
2.6 |
1.6 |
320 |
330 |
CS |
6.4 |
|
4.3 |
|
1.5 |
1.3 |
23 |
40 |
CT |
|
1.7 |
|
21.3 |
0.6 |
1.1 |
208 |
135 |
CU |
13.2 |
12.8 |
3.1 |
1.7 |
2.5 |
2.6 |
45 |
57 |
CV |
2.6 |
|
-6.9 |
|
|
|
119 |
76 |
[1] Administered by the
Human Monitoring Laboratory (HML), Radiation Protection Bureau, Health Canada